Literature DB >> 10949578

Adhesion receptors and cell invasion: mechanisms of integrin-guided degradation of extracellular matrix.

J Ivaska1, J Heino.   

Abstract

The integrins are a large family of heterodimeric cell adhesion receptors mediating cell-matrix and cell-cell adhesion. They seem to play a central role in cell migration and invasion and are therefore essential in processes such as healing of tissue injuries and the progression of human cancer. Integrins function in cell invasion by mediating cell movement on matrix molecules and also by regulating the expression of matrix-degrading enzymes, namely the matrix metalloproteinases. Here we review recent findings on the mechanisms by which integrins regulate matrix degradation. A novel, multistep model of integrin-guided collagen degradation is proposed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10949578     DOI: 10.1007/s000180050496

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  30 in total

1.  Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics.

Authors:  M P Lutolf; J L Lauer-Fields; H G Schmoekel; A T Metters; F E Weber; G B Fields; J A Hubbell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-09       Impact factor: 11.205

2.  Overexpression of Hsp27 affects the metastatic phenotype of human melanoma cells in vitro.

Authors:  Silke Aldrian; Franz Trautinger; Ilse Fröhlich; Walter Berger; Michael Micksche; Ingela Kindas-Mügge
Journal:  Cell Stress Chaperones       Date:  2002-04       Impact factor: 3.667

3.  Creation of bony microenvironment with CaP and cell-derived ECM to enhance human bone-marrow MSC behavior and delivery of BMP-2.

Authors:  Yunqing Kang; Sungwoo Kim; Ali Khademhosseini; Yunzhi Yang
Journal:  Biomaterials       Date:  2011-05-31       Impact factor: 12.479

4.  Cleavage of myelin associated glycoprotein by matrix metalloproteinases.

Authors:  Elizabeth Milward; Kee Jun Kim; Arek Szklarczyk; Thien Nguyen; Giorgia Melli; Mamatha Nayak; Deepa Deshpande; Chantel Fitzsimmons; Ahmet Hoke; Douglas Kerr; John W Griffin; Peter A Calabresi; Katherine Conant
Journal:  J Neuroimmunol       Date:  2007-12-11       Impact factor: 3.478

5.  The glycocalyx maintains a cell surface pH nanoenvironment crucial for integrin-mediated migration of human melanoma cells.

Authors:  Hermann Krähling; Sabine Mally; Johannes A Eble; Josette Noël; Albrecht Schwab; Christian Stock
Journal:  Pflugers Arch       Date:  2009-06-28       Impact factor: 3.657

6.  Embryonic vasculogenesis in nodular melanomas and tumour differentiation.

Authors:  Bhanu Iyengar; Avantika V Singh
Journal:  Pathol Oncol Res       Date:  2011-01-04       Impact factor: 3.201

7.  The role of mediators of cell invasiveness, motility, and migration in the pathogenesis of silent corticotroph adenomas.

Authors:  Ozgur Mete; Caroline Hayhurst; Hussein Alahmadi; Eric Monsalves; Hasan Gucer; Fred Gentili; Shereen Ezzat; Sylvia L Asa; Gelareh Zadeh
Journal:  Endocr Pathol       Date:  2013-12       Impact factor: 3.943

8.  Converging signals synergistically activate the LAMC2 promoter and lead to accumulation of the laminin gamma 2 chain in human colon carcinoma cells.

Authors:  Jørgen Olsen; Lene T Kirkeby; Marianne M Brorsson; Sally Dabelsteen; Jesper T Troelsen; Randi Bordoy; Kirsten Fenger; Lars-Inge Larsson; Patricia Simon-Assmann
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

9.  Fibronectin-integrin mediated signaling in human cervical cancer cells (SiHa).

Authors:  Gargi Maity; Shabana Fahreen; Aniruddha Banerji; Paromita Roy Choudhury; Triparna Sen; Anindita Dutta; Amitava Chatterjee
Journal:  Mol Cell Biochem       Date:  2009-10-09       Impact factor: 3.396

10.  Analytic study of three-dimensional single cell migration with and without proteolytic enzymes.

Authors:  Rebecca H Chisholm; Barry D Hughes; Kerry A Landman; Muhammad H Zaman
Journal:  Cell Mol Bioeng       Date:  2013-06-01       Impact factor: 2.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.